Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (271-280 of 496) with videos related to

Pageof 50
Sort By:
Cancers|June 10, 2023
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in IndiaDivya Pillai, Jyoti Narayan, Aleksandra Gentry-Maharaj, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured InterviewsFaiza Gaba, Samuel Oxley, Xinting Liu, et al.
Ebiomedicine|December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation CarriersMartin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
Cancer Genomics & Proteomics|November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaksJohn F Timms, Usha Menon, Dmitry Devetyarov, et al.
Oncotarget|December 2, 2016
Novel risk models for early detection and screening of ovarian cancerMatthew R Russell, Alfonsina D'Amato, Ciaren Graham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
BMJ Open Respiratory Research|June 9, 2026
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocolSindhu Bhaarrati Naidu, Gabrielle Guvensen, Honghan Wu, et al.
Clinical and Translational Science|February 1, 2020
Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program SiteTitilayo O Ilori, Emma Viera, Jillian Wilson, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian CancerWei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, et al.
Pageof 50

Showing results (271-280 of 496) with videos related to

Sort By:
Pageof 50
Cancers|June 10, 2023
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in IndiaDivya Pillai, Jyoti Narayan, Aleksandra Gentry-Maharaj, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured InterviewsFaiza Gaba, Samuel Oxley, Xinting Liu, et al.
Ebiomedicine|December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation CarriersMartin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
Cancer Genomics & Proteomics|November 17, 2011
Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaksJohn F Timms, Usha Menon, Dmitry Devetyarov, et al.
Oncotarget|December 2, 2016
Novel risk models for early detection and screening of ovarian cancerMatthew R Russell, Alfonsina D'Amato, Ciaren Graham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
BMJ Open Respiratory Research|June 9, 2026
Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocolSindhu Bhaarrati Naidu, Gabrielle Guvensen, Honghan Wu, et al.
Clinical and Translational Science|February 1, 2020
Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program SiteTitilayo O Ilori, Emma Viera, Jillian Wilson, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian CancerWei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, et al.
Pageof 50